Skip to content

Substance Use Disorders and the Pregnant and Postpartum Mother/Infant Dyad: A Symposium to Enhance lnterprofessional Practice

Saturday, April 20, 2024

Hershey Lodge

325 University Dr.
Hershey, PA 17033

More about the location

Select this button to navigate the sections of this page

Conference ID

D7019

PURPOSE

The overall purpose of this Symposium is to provide state-of-the-art education and training to health care providers in both hospital and community settings around the compassionate and evidence-based care of pregnant and post-partum women who are using licit and illicit substances and their substance-exposed infants.

AUDIENCE

Hospital-based health care workers and providers who interact with and provide care to pregnant and post-partum women with substance use disorders and with their substance-exposed infants in outpatient and inpatient hospital settings and community programs. This includes the full range of health care workers such as medical office assistants, nursing staff, social workers, advanced practice providers, PAs and physicians, as well as community-based health care workers and providers.

OVERALL OBJECTIVES

  • List three strategies for providing compassionate care to women with substance use disorders (SUDs).
  • Describe the short- and long-term developmental and behavioral consequences in infants exposed to prenatal substances.
  • Describe the management of co-morbid mental health concerns, infections, and substance use disorders in pregnant and postpartum women using substances.

AGENDA

  • 8 a.m. | Breakfast and Registration
  • 8:45 a.m. | Introduction and Welcome
    Richard Legro, MD
    Sheryl Ryan, MD
    Yatin Vyas, MBBS, MD
  • 9 a.m. | Plenary Speaker: Providing Evidence-Based Compassionate Care to Pregnant and Post-Partum Women With Substance Use Disorders
    Hendree Jones, PhD
  • 10 a.m. | The Maternal SUD Program at Penn State
    John Dougherty, MD
  • 10:45 a.m. | Break
  • 11 a.m. | Plenary Speaker: Prenatal Substance Exposure and Developmental Outcomes
    Rina Eiden, PhD
  • 11:45 a.m. | Question and Answer Panel
    Rina Eiden, PhD
    John Dougherty, MD
    Hendree Jones, PhD
  • 12:15 p.m. | Lunch
  • 1:30 p.m. | Panel Presentation and Discussion: The Challenges of Screening for and Reporting Substance Use During Pregnancy and Plans of Safe Care
    Taffy Anderson, MD
    Tammy Corr, DO
    Channing Griffith, MSW, LSW
    Marisa McClellan, Esq
  • 2:30 p.m. | Question and Answer
  • 2:45 p.m. | Break and Move to Breakout Sessions
  • 3 p.m. | Breakout Session 1  

    The Treatment of Co-Morbid Mental Health Conditions During Pregnancy

    Marissa Beal, DO

    Assessment and Treatment of NOWS: Birth Through Early Childhood
    Tammy Corr, DO

    No Longer an Aberrancy: Medications for Opioid Use Disorder in Pregnancy
    Bhavna Bali, MD
  • 3:45 p.m. | Move to Breakout Sessions
  • 4 p.m. | Breakout Session 2

    Screening and Treatment of Sexually Transmitted Infections (STIs) and Harm Reduction in Women with SUDs
    Jonathan Nunez, MD

    Interdisciplinary Community-Based Approaches and Resources To Support Parenting Women With SUDs
    CJ Bissonette
    Amanda Jernigan, LCSW

    Cannabis, Alcohol and Nicotine Use and Breastfeeding
    Sheryl Ryan, MD
  • 4:45 p.m. | Final Remarks and Adjournment
    Taffy Anderson, MD
    Sheryl Ryan, MD

CREDIT

AMA

Penn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Penn State College of Medicine designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses Using AMA

Nurses will receive a certificate from Penn State College of Medicine verifying their participation in 5.75 hours of approved continuing medical education. Continuing education activities which are approved by accredited institutions of higher education and that are relevant to patient care or professional nursing meet the requirements of mandatory continuing education for registered nurses in Pennsylvania, as required by the Pennsylvania State Board of Nursing. The Board of Nursing recommends that nurses retain their certificates for a period of at least five years. Additional information is available through the State Board of Nursing at: https://ce.med.psu.edu/nurse-credits

Social Work

Penn State is an approved provider as defined by Pa. Code Sections 47.36(a)(3), 48.36(a)(3), and 49.36(a)(3). Social workers, marriage and family therapists, and professional counselors licensed by the state of Pennsylvania can earn 5.75 clock hours of continuing education for completing this course.

FEE

There is no fee, but registration is required.

Evaluation

A completed evaluation is required in order to receive a certificate for attending this activity. Please complete and submit the evaluation within the specified time frame.

Cancellations

The University reserves the right to cancel or postpone any course or activity because of insufficient enrollment or other unforeseen circumstances. If a program is canceled or postponed, the University will refund any program registration fees paid but cannot be held responsible for any related costs, charges or expenses, including cancellation/change charges assessed by airlines or travel agencies.

Program registrants who are experiencing illness or have been exposed to anyone who is ill should contact the Continuing Education office before attending any in-person activities.

Changes

Content and speakers for all programs are subject to change. Registrants will be notified of any significant updates.

COVID-19

On-campus educational activities provided by Penn State College of Medicine Continuing Education are required to follow healthcare facility guidelines. Off-campus events provided by Penn State College of Medicine Continuing Education follow the COVID-19 requirements of that venue. We ask that all participants respect that some attendees may still choose to wear masks for activities. Check the venue website for the latest requirements and recommendations. Please do not attend this activity if you have symptoms or have been exposed to someone with COVID-19. By attending the activity, you attest that you do not have any symptoms suggestive of COVID-19, which may include fever, cough, shortness of breath, sore throat, loss of taste, loss of smell or any other sign of illness.

Access (ADA)

Penn State encourages people with disabilities to participate in its programs and activities. Participants who anticipate needing any type of special accommodation or who have questions about the physical access provided should contact the Continuing Education office at least one week in advance of participation or visit.

Disclosure and Conflict of Interest (COI and Educational Balance)

It is Penn State policy to ensure balance, independence, objectivity and scientific rigor in all educational activities. Penn State has a process in place to mitigate any relevant financial relationships with commercial companies disclosed by faculty, course directors and planning committee members. Complete disclosure information will be provided to participants at the beginning of the activity.

University Nondiscrimination Policy

This publication is available in alternative media on request. The Pennsylvania State University is committed to the policy that all persons shall have equal access to programs, facilities, admission and employment without regard to personal characteristics not related to ability, performance or qualifications as determined by University policy or by state or federal authorities. It is the policy of the University to maintain an academic and work environment free of discrimination, including harassment. The Pennsylvania State University prohibits discrimination and harassment against any person because of age, ancestry, color, disability or handicap, genetic information, national origin, race, religious creed, sex, sexual orientation, gender identity or veteran status and retaliation due to the reporting of discrimination or harassment. Discrimination, harassment or retaliation against faculty, staff or students will not be tolerated at The Pennsylvania State University. Direct all inquiries regarding the Nondiscrimination Policy to the Affirmative Action Director, The Pennsylvania State University, 328 Boucke Building, University Park, PA 16802-5901; 814-863-0471 (TTY). US M.Ed. D7019

Jump to ...